DEFINITIVE HEALTHCARE CORP (DH) Fundamental Analysis & Valuation

NASDAQ:DH • US24477E1038

1.22 USD
0 (0%)
At close: Mar 5, 2026
1.22 USD
0 (0%)
After Hours: 3/5/2026, 8:00:02 PM

This DH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

DH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of DH have multiple concerns. DH has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

3

1. DH Profitability Analysis

1.1 Basic Checks

  • DH had positive earnings in the past year.
  • DH had a positive operating cash flow in the past year.
  • DH had negative earnings in each of the past 5 years.
  • DH had a positive operating cash flow in each of the past 5 years.
DH Yearly Net Income VS EBIT VS OCF VS FCFDH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

  • DH has a Return On Assets of -18.89%. This is comparable to the rest of the industry: DH outperforms 48.57% of its industry peers.
  • DH has a Return On Equity (-49.42%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -18.89%
ROE -49.42%
ROIC N/A
ROA(3y)-22.63%
ROA(5y)-13.82%
ROE(3y)-55.3%
ROE(5y)-33.74%
ROIC(3y)N/A
ROIC(5y)N/A
DH Yearly ROA, ROE, ROICDH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • With an excellent Gross Margin value of 75.88%, DH belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
  • DH's Gross Margin has been stable in the last couple of years.
  • DH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.08%
GM growth 5Y0.44%
DH Yearly Profit, Operating, Gross MarginsDH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

3

2. DH Health Analysis

2.1 Basic Checks

  • DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DH has been reduced compared to 1 year ago.
  • The number of shares outstanding for DH has been reduced compared to 5 years ago.
  • Compared to 1 year ago, DH has a worse debt to assets ratio.
DH Yearly Shares OutstandingDH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DH Yearly Total Debt VS Total AssetsDH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of -0.90, we must say that DH is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.90, DH is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of DH is 4.45, which is a neutral value as it means it would take DH, 4.45 years of fcf income to pay off all of its debts.
  • DH has a better Debt to FCF ratio (4.45) than 62.86% of its industry peers.
  • DH has a Debt/Equity ratio of 0.56. This is a neutral value indicating DH is somewhat dependend on debt financing.
  • DH has a worse Debt to Equity ratio (0.56) than 77.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.45
Altman-Z -0.9
ROIC/WACCN/A
WACC8.61%
DH Yearly LT Debt VS Equity VS FCFDH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.64 indicates that DH should not have too much problems paying its short term obligations.
  • The Current ratio of DH (1.64) is worse than 60.00% of its industry peers.
  • A Quick Ratio of 1.64 indicates that DH should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.64, DH is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
DH Yearly Current Assets VS Current LiabilitesDH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

3

3. DH Growth Analysis

3.1 Past

  • The earnings per share for DH have decreased strongly by -28.57% in the last year.
  • Measured over the past 5 years, DH shows a small growth in Earnings Per Share. The EPS has been growing by 1.37% on average per year.
  • The Revenue has decreased by -4.24% in the past year.
  • The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)-28.57%
EPS 3Y1.37%
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)-4.24%
Revenue growth 3Y2.74%
Revenue growth 5Y15.34%
Sales Q2Q%-1.21%

3.2 Future

  • The Earnings Per Share is expected to decrease by -0.37% on average over the next years.
  • DH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.24% yearly.
EPS Next Y-16.1%
EPS Next 2Y-3.99%
EPS Next 3Y-0.37%
EPS Next 5YN/A
Revenue Next Year-5.78%
Revenue Next 2Y-2.73%
Revenue Next 3Y0.24%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DH Yearly Revenue VS EstimatesDH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
DH Yearly EPS VS EstimatesDH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

7

4. DH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 4.88, which indicates a rather cheap valuation of DH.
  • DH's Price/Earnings ratio is rather cheap when compared to the industry. DH is cheaper than 100.00% of the companies in the same industry.
  • DH is valuated cheaply when we compare the Price/Earnings ratio to 26.74, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 5.82, the valuation of DH can be described as very cheap.
  • 97.14% of the companies in the same industry are more expensive than DH, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of DH to the average of the S&P500 Index (24.82), we can say DH is valued rather cheaply.
Industry RankSector Rank
PE 4.88
Fwd PE 5.82
DH Price Earnings VS Forward Price EarningsDH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • DH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DH is cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DH is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.44
EV/EBITDA 2.38
DH Per share dataDH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.99%
EPS Next 3Y-0.37%

0

5. DH Dividend Analysis

5.1 Amount

  • No dividends for DH!.
Industry RankSector Rank
Dividend Yield 0%

DH Fundamentals: All Metrics, Ratios and Statistics

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (3/5/2026, 8:00:02 PM)

After market: 1.22 0 (0%)

1.22

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners31.89%
Inst Owner Change-4.79%
Ins Owners7.45%
Ins Owner Change22.2%
Market Cap127.45M
Revenue(TTM)241.52M
Net Income(TTM)-138.93M
Analysts75
Price Target3.98 (226.23%)
Short Float %8.3%
Short Ratio4.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.6%
Min EPS beat(2)-4.36%
Max EPS beat(2)23.57%
EPS beat(4)3
Avg EPS beat(4)39.3%
Min EPS beat(4)-4.36%
Max EPS beat(4)101.59%
EPS beat(8)6
Avg EPS beat(8)23.08%
EPS beat(12)9
Avg EPS beat(12)24.15%
EPS beat(16)13
Avg EPS beat(16)27%
Revenue beat(2)1
Avg Revenue beat(2)-0.86%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.29%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-2%
Max Revenue beat(4)2.29%
Revenue beat(8)2
Avg Revenue beat(8)-0.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.16%
Revenue beat(16)4
Avg Revenue beat(16)-0.98%
PT rev (1m)0%
PT rev (3m)-3.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.82%
EPS NY rev (1m)0%
EPS NY rev (3m)6.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE 4.88
Fwd PE 5.82
P/S 0.53
P/FCF 3.44
P/OCF 2.37
P/B 0.45
P/tB N/A
EV/EBITDA 2.38
EPS(TTM)0.25
EY20.49%
EPS(NY)0.21
Fwd EY17.19%
FCF(TTM)0.35
FCFY29.07%
OCF(TTM)0.51
OCFY42.19%
SpS2.31
BVpS2.69
TBVpS-1.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.89
Profitability
Industry RankSector Rank
ROA -18.89%
ROE -49.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.88%
FCFM 15.34%
ROA(3y)-22.63%
ROA(5y)-13.82%
ROE(3y)-55.3%
ROE(5y)-33.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.08%
GM growth 5Y0.44%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.45
Debt/EBITDA 3.95
Cap/Depr 29.8%
Cap/Sales 6.92%
Interest Coverage N/A
Cash Conversion 136.16%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z -0.9
F-Score5
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)19.81%
Cap/Depr(5y)17.06%
Cap/Sales(3y)4.33%
Cap/Sales(5y)4.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3Y1.37%
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y-16.1%
EPS Next 2Y-3.99%
EPS Next 3Y-0.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.24%
Revenue growth 3Y2.74%
Revenue growth 5Y15.34%
Sales Q2Q%-1.21%
Revenue Next Year-5.78%
Revenue Next 2Y-2.73%
Revenue Next 3Y0.24%
Revenue Next 5YN/A
EBIT growth 1Y-70.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.77%
EBIT Next 3Y-11.92%
EBIT Next 5YN/A
FCF growth 1Y-19.18%
FCF growth 3Y10.79%
FCF growth 5Y11.17%
OCF growth 1Y-7.59%
OCF growth 3Y14.76%
OCF growth 5Y18.29%

DEFINITIVE HEALTHCARE CORP / DH FAQ

Can you provide the ChartMill fundamental rating for DEFINITIVE HEALTHCARE CORP?

ChartMill assigns a fundamental rating of 3 / 10 to DH.


Can you provide the valuation status for DEFINITIVE HEALTHCARE CORP?

ChartMill assigns a valuation rating of 7 / 10 to DEFINITIVE HEALTHCARE CORP (DH). This can be considered as Undervalued.


Can you provide the profitability details for DEFINITIVE HEALTHCARE CORP?

DEFINITIVE HEALTHCARE CORP (DH) has a profitability rating of 3 / 10.


What are the PE and PB ratios of DEFINITIVE HEALTHCARE CORP (DH) stock?

The Price/Earnings (PE) ratio for DEFINITIVE HEALTHCARE CORP (DH) is 4.88 and the Price/Book (PB) ratio is 0.45.